Yep - it’s impossible to separate experimental tokens vs value creating ones.

Ultimately the performance will be assessed via the income statement and cash flows of customers of the model producers.

Frankly in the window pre-IPO it’s in the best interests of OAI et al to show a line going to the top-right in relation to tokens, in their prospectus. What does that mean?

Strategic manipulation.